Latest Updates

Increasing investments in AI in drug discovery by big pharma allow them to apply machine learning to identify and screen potential…

Aptar Pharma will also be hosting a half day seminar on Friday morning, June 22 at the event

MSF has released a statement with several proposals for the hub to ensure the delivery of patient-needs-driven R&D for new and…

Promoted by Enerzal – Balanced Energy and Electrolyte Drink, a FDC Ltd brand, The Enerzal Doctors’ Badminton Championship is a…

The college has transformed its learning environment and operations, with anytime, anywhere access to coursework and research…

In FY 2018, the company posts Rs 981 crore PAT

PAT is at Rs 1,411 crore in FY 2018

Russian Ministry of Health has approved Sava Healthcare's DPI capsules manufacturing line for respiratory therapeutic segment

To treat metastatic castration-resistant prostate cancer in combination with methylprednisolone

The R&D investments in the quarter ramped up to ~7.6 per cent of revenues Cipla Limited announced its audited consolidated…

CPhI Conferences will host the ‘The 3rd edition of The India Packaging Awards’ on 24th May 2018

Ryaltris is for seasonal allergic rhinitis and it is formerly known as GSP 301 nasal spray, and it is the company’s leading…

There are only nine biosimilars available on the US market to date and it is estimated that only three per cent of spending on…

Organised by Clarivate Analytics, it honours India’s most disruptive innovators

The company has already commenced supplies of the product to the US market

CDSCO website will release a notification about the new provision for sale of medicines in India

Manufacturing facilities at Patalganga and Rabale were inspected successfully

Revenues were at Rs 6,775 million in Q4 FY18

Cipla will get exclusive marketing rights for five years in India for critical limb ischemia due to atherosclerotic peripheral…

Syngene said Biocon has sold the shares for achieving minimum public shareholding requirement